Wave Life Sciences Ltd.
NASDAQ:WVE · NASDAQ Global Market
+$0.10 today
Vol 5.07M · Avg 4.86M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-11.49%
Period High
$21.31
Period Low
$5.66
Latest
$6.16
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Spyre Therapeutics, Inc.
NASDAQ:SYRE
$5.27B
Terns Pharmaceuticals, Inc.
TERN
$4.77B
Enliven Therapeutics, Inc.
NASDAQ:ELVN
$2.73B
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$1.70B
Precigen, Inc.
NASDAQ:PGEN
$1.39B
Amylyx Pharmaceuticals, Inc.
NASDAQ:AMLX
$1.28B
Tourmaline Bio, Inc.
TRML
$1.23B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
$880.93M
Zenas BioPharma, Inc.
NASDAQ:ZBIO
$855.13M
Upstream Bio, Inc.
NASDAQ:UPB
$340.67M
What is the latest WVE filing?
The latest filing shown is 8-K dated May 18, 2026.
How many recent filings does WVE have?
Intrinsic Alpha currently shows 20 recent filings for WVE.
Explore More
Continue the stock analysis
Jump to another research area for this company.